74 related articles for article (PubMed ID: 7563170)
1. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia.
Guidi AJ; Abu-Jawdeh G; Berse B; Jackman RW; Tognazzi K; Dvorak HF; Brown LF
J Natl Cancer Inst; 1995 Aug; 87(16):1237-45. PubMed ID: 7563170
[TBL] [Abstract][Full Text] [Related]
2. Exosomes from cervical cancer cells facilitate pro-angiogenic endothelial reconditioning through transfer of Hedgehog-GLI signaling components.
Bhat A; Yadav J; Thakur K; Aggarwal N; Tripathi T; Chhokar A; Singh T; Jadli M; Bharti AC
Cancer Cell Int; 2021 Jun; 21(1):319. PubMed ID: 34167524
[TBL] [Abstract][Full Text] [Related]
3. Stomatitis and VEGFR-Tyrosine Kinase Inhibitors (VR-TKIs): A Review of Current Literature in 4369 Patients.
Arena C; Troiano G; De Lillo A; Testa NF; Lo Muzio L
Biomed Res Int; 2018; 2018():5035217. PubMed ID: 29992147
[TBL] [Abstract][Full Text] [Related]
4. Modulatory Effects of Chemoradiation on Angiogenic Factors and Laminin in Cervical Cancer: Link with Treatment Response.
Sharma M; Khan R; Aggarwal M; Sharma A
Asian Pac J Cancer Prev; 2017 Nov; 18(11):2937-2944. PubMed ID: 29172262
[TBL] [Abstract][Full Text] [Related]
5. The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.
Woodby B; Scott M; Bodily J
Prog Mol Biol Transl Sci; 2016; 144():169-238. PubMed ID: 27865458
[TBL] [Abstract][Full Text] [Related]
6. VEGF +936 C/T Genetic Polymorphism in Patients with Cervical Dysplasia.
Rotar IC; Dumitras DE; Popp RA; Petrisor FM; Cotutiu P; Stamatian F; Muresan D
Anal Cell Pathol (Amst); 2016; 2016():6074275. PubMed ID: 27812483
[No Abstract] [Full Text] [Related]
7. Immunohistochemical Expression of VEGF and Podoplanin in Uterine Cervical Squamous Intraepithelial Lesions.
Belfort-Mattos PN; Focchi GR; Ribalta JC; Megale De Lima T; Nogueira Carvalho CR; Kesselring Tso F; De Góis Speck NM
Dis Markers; 2016; 2016():8293196. PubMed ID: 27313335
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy and molecular targeting therapy for recurrent cervical cancer.
Tsuda N; Watari H; Ushijima K
Chin J Cancer Res; 2016 Apr; 28(2):241-53. PubMed ID: 27199523
[TBL] [Abstract][Full Text] [Related]
9. Development of bevacizumab in advanced cervical cancer: pharmacodynamic modeling, survival impact and toxicology.
Eskander RN; Tewari KS
Future Oncol; 2015; 11(6):909-22. PubMed ID: 25760973
[TBL] [Abstract][Full Text] [Related]
10. New molecular targets against cervical cancer.
Duenas-Gonzalez A; Serrano-Olvera A; Cetina L; Coronel J
Int J Womens Health; 2014; 6():1023-31. PubMed ID: 25525394
[TBL] [Abstract][Full Text] [Related]
11. Immunological effects and therapeutic role of C5a in cancer.
Darling VR; Hauke RJ; Tarantolo S; Agrawal DK
Expert Rev Clin Immunol; 2015 Feb; 11(2):255-63. PubMed ID: 25387724
[TBL] [Abstract][Full Text] [Related]
12. Targeting angiogenesis in advanced cervical cancer.
Eskander RN; Tewari KS
Ther Adv Med Oncol; 2014 Nov; 6(6):280-92. PubMed ID: 25364393
[TBL] [Abstract][Full Text] [Related]
13. Effects of Acanthus ebracteatus Vahl on tumor angiogenesis and on tumor growth in nude mice implanted with cervical cancer.
Mahasiripanth T; Hokputsa S; Niruthisard S; Bhattarakosol P; Patumraj S
Cancer Manag Res; 2012; 4():269-79. PubMed ID: 22977311
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the angiogenesis growth factors in psoriasis vulgaris.
Liew SC; Das-Gupta E; Chakravarthi S; Wong SF; Lee N; Safdar N; Jamil A
BMC Res Notes; 2012 Jul; 5():201. PubMed ID: 22537619
[TBL] [Abstract][Full Text] [Related]
15. Seminal plasma enhances cervical adenocarcinoma cell proliferation and tumour growth in vivo.
Sutherland JR; Sales KJ; Jabbour HN; Katz AA
PLoS One; 2012; 7(3):e33848. PubMed ID: 22442729
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic advances in women's cancers.
Carroll AR; Coleman RL; Sood AK
Front Biosci (Schol Ed); 2011 Jan; 3(1):82-97. PubMed ID: 21196359
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of the tumor vasculature.
Nagy JA; Chang SH; Shih SC; Dvorak AM; Dvorak HF
Semin Thromb Hemost; 2010 Apr; 36(3):321-31. PubMed ID: 20490982
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors.
Lockhart AC; Rothenberg ML; Dupont J; Cooper W; Chevalier P; Sternas L; Buzenet G; Koehler E; Sosman JA; Schwartz LH; Gultekin DH; Koutcher JA; Donnelly EF; Andal R; Dancy I; Spriggs DR; Tew WP
J Clin Oncol; 2010 Jan; 28(2):207-14. PubMed ID: 19949018
[TBL] [Abstract][Full Text] [Related]
19. Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.
Hensley ML; Sill MW; Scribner DR; Brown J; Debernardo RL; Hartenbach EM; McCourt CK; Bosscher JR; Gehrig PA
Gynecol Oncol; 2009 Dec; 115(3):460-5. PubMed ID: 19811811
[TBL] [Abstract][Full Text] [Related]
20. Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting.
Bhattacharya R; Kwon J; Li X; Wang E; Patra S; Bida JP; Bajzer Z; Claesson-Welsh L; Mukhopadhyay D
J Cell Sci; 2009 Apr; 122(Pt 7):1025-34. PubMed ID: 19295129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
